FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a combination for the prevention, correction and therapy of pain related to neurodegeneration and/or associated with somatoform disorders, characterised by the fact that it consists of buspirone and doxepin taken in therapeutically effective amounts.
EFFECT: invention provides creating the combination providing the prolonged analgesic effect, including in persistent chronic pains.
5 cl, 2 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING NEUROPATHIC PAIN AND ASSOCIATED WITH IT SYNDROMES | 2005 |
|
RU2433825C2 |
| SIGMA-RECEPTOR LIGANDS FOR PREVENTING OR TREATING PAIN CAUSED BY CHEMOTHERAPY | 2010 |
|
RU2543382C2 |
| USING COMPOUNDS BINDING TO SIGMA RECEPTOR LIGANDS FOR TREATING NEUROPATHIC PAIN PROGRESSION CAUSED BY CHEMOTHERAPY | 2009 |
|
RU2537226C2 |
| COMBINATIONS OF PALMITOYLETHANOLAMIDE FOR TREATING CHRONIC PAIN | 2018 |
|
RU2701720C1 |
| NEW APPLICATION OF UNITED AGONISTS 5-HT AND INHIBITORS OF SEROTONIN REVERSE CAPTURE | 2001 |
|
RU2302243C2 |
| COMBINATION OF FLUPIRTINE AND CYCLOBENZAPRINE FOR TREATMENT OF PAIN SYNDROMES | 2017 |
|
RU2680244C1 |
| DERIVATIVE OF PYRROLIDINE ACETAMIDE OR ITS COMBINATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | 2000 |
|
RU2261093C2 |
| CARBAMATE COMPOUNDS FOR USING IN PROPHYLAXIS OR TREATMENT OF NEUROPATHIC PAIN AND PAIN ASSOCIATED WITH CLASTER AND MIGRAINE HEADACHE | 2002 |
|
RU2303445C2 |
| PREGNANDIONS OR PREGNANDIOLS APPLICATION AS NEUROPATHIC ANALGESIC AGENTS | 2002 |
|
RU2346690C2 |
| THERAPEUTIC ANALGESIC | 2009 |
|
RU2486900C2 |
